Wird geladen...
Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...
Gespeichert in:
| Veröffentlicht in: | Ann Clin Transl Neurol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/ https://ncbi.nlm.nih.gov/pubmed/26783546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|